JAMP Venlafaxine XR recall in Canada: Mislabelling could lead to overdose
In plain language
This recall involves certain bottles of JAMP Venlafaxine XR 37.5 mg capsules sold in Canada. It's being recalled because some bottles labelled as 37.5 mg may contain 150 mg capsules, which could lead to an overdose. Stop using the product if it contains incorrect capsules and contact your pharmacy immediately.
What to do
- Stop using the product if it contains incorrect capsules.
- Check the capsules in your pharmacy bottle to ensure they are 37.5 mg (grey/pink).
- If unsure or if capsules are 150 mg (caramel), contact your pharmacist.
- Return affected product to your pharmacy for proper disposal.
- Contact your healthcare professional if you have taken the wrong dose.
- Seek medical attention immediately for any serious side effects.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP Venlafaxine XR 37.5 mg
Lot: PTC5140A
Date codes: 09/2024
Why this matters
Overdose risk due to mislabelling
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 09/2024
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: PTC5140A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Overdose risk due to mislabelling
What should consumers do?
Stop using the product if it contains incorrect capsules. Check the capsules in your pharmacy bottle to ensure they are 37.5 mg (grey/pink). If unsure or if capsules are 150 mg (caramel), contact your pharmacist. Return affected product to your pharmacy for proper disposal. Contact your healthcare professional if you have taken the wrong dose. Seek medical attention immediately for any serious side effects.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Overdose risk due to mislabelling
When was this product recalled?
This product was recalled on June 21, 2023.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves certain bottles of JAMP Venlafaxine XR 37.5 mg capsules sold in Canada. It's being recalled because some bottles labelled as 37.5 mg may contain 150 mg capsules, which could lead to an overdose. Stop using the product if it contains incorrect capsules and contact your pharmacy immediately.